|
contents | america | ||||
| The Capitalizing On The Thriving Therapeutics Market Summit IBC Life Sciences is pleased to announce Capitalizing on the Thriving Therapeutics Market, a pre-conference summit that will cover scientific process, business trends, next generation products, new technologies and opportunities in the antibody therapeutics market. This summit will take place on August 6, 2007 at the Drug Discovery & Development of Innovative Therapeutics World Congress being held on August 6-9, 2007 at the Word Trade Center in Boston, MA. The Capitalizing on the Thriving Therapeutics Market Summit will include presentations; interactive sessions and panel discussions from over from 25 speakers. In addition, Carols F. Barbos of the Scripps Research Institute will give the featured presentation on CovX-bodies from conception to clinic which will present studies concerning the superior biological activity bestowed upon small molecules and peptides by this approach. Summit session topics include CovX-bodies: from Conception to Clinic, Engineering "Druggable" Antibodies: Current and Next Generation Approaches, Preclinical and Clinical Design of Antibody Drugs, Production and Manufacturing Issues for Antibodies, Trends in Deal-Making, M&A, Licensing and IP for Antibody Drugs. Informatics throughout the discovery & development value chain will cover how small, mid-size and large companies are tackling the tough question of how to optimize an informatics platform to help make smart business decisions. In addition it will address how to identify where the holes and needs are in current technologies, how to apply predictive models, and how to integrate chemical and biological information. A featured presentation will be given by Ingid E. Akerblom of Merck and Co. entitled Discovery and development informatics: blurring the lines through a combined process and technology approach. The Drug Discovery & Development of Innovative Therapeutics (DDT) World Congress expects more than 3, 000 pharmaceutical, biotechnology, government and academic researchers, executives and technology providers to participate. The event focuses on scientific innovations, new approaches and business strategies that are helping companies to accelerate movement of compounds into the clinic. In addition the four conference tracks this year's program includes three pre-conference summits, six focus area sessions and three post-conference workshops. DDT also provides one of the largest exhibitions of drug discovery and development related products, technologies and services in the world. write your comments about the article :: © 2007 Exhibition News :: home page |